Nab-Paclitaxel as new Therapeutic Option for Pancreatic Cancer

被引：0
|
作者：
Michl, P. [1 ]
机构：
[1] Univ Marburg, Klin Gastroenterol Endokrinol & Stoffwechsel, D-35043 Marburg, Germany
来源：
ZEITSCHRIFT FUR GASTROENTEROLOGIE | 2013年 / 51卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
下载
收藏
页码：1329 / 1330
页数：2
相关论文
共 50 条
  • [1] nab-Paclitaxel for the treatment of pancreatic cancer
    Kim, George
    CANCER MANAGEMENT AND RESEARCH, 2017, 9 : 85 - 96
  • [2] Nab-paclitaxel shows promise in pancreatic cancer
    Baker, Holly
    LANCET ONCOLOGY, 2013, 14 (13): : E585 - E585
  • [3] Stromal disrupting effects of nab-paclitaxel in pancreatic cancer
    Alvarez, R.
    Musteanu, M.
    Garcia-Garcia, E.
    Lopez-Casas, P. P.
    Megias, D.
    Guerra, C.
    Munoz, M.
    Quijano, Y.
    Cubillo, A.
    Rodriguez-Pascual, J.
    Plaza, C.
    de Vicente, E.
    Prados, S.
    Tabernero, S.
    Barbacid, M.
    Lopez-Rios, F.
    Hidalgo, M.
    BRITISH JOURNAL OF CANCER, 2013, 109 (04) : 926 - 933
  • [4] Case report of nab-paclitaxel in metastatic pancreatic cancer
    Haslbauer F.
    memo - Magazine of European Medical Oncology, 2014, 7 (1) : 39 - 42
  • [5] Stromal disrupting effects of nab-paclitaxel in pancreatic cancer
    R Alvarez
    M Musteanu
    E Garcia-Garcia
    P P Lopez-Casas
    D Megias
    C Guerra
    M Muñoz
    Y Quijano
    A Cubillo
    J Rodriguez-Pascual
    C Plaza
    E de Vicente
    S Prados
    S Tabernero
    M Barbacid
    F Lopez-Rios
    M Hidalgo
    British Journal of Cancer, 2013, 109 : 926 - 933
  • [6] Nab-paclitaxel: potential for the treatment of advanced pancreatic cancer
    Al-Hajeili, Marwan
    Azmi, Asfar S.
    Choi, Minsig
    ONCOTARGETS AND THERAPY, 2014, 7 : 187 - 192
  • [7] Clinical efficacy of nab-paclitaxel in patients with metastatic pancreatic cancer
    De Luca, Rossella
    Blasi, Livio
    Alu, Massimiliano
    Gristina, Valerio
    Cicero, Giuseppe
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 1769 - 1775
  • [8] A modified regimen of nab-paclitaxel and gemcitabine in advanced pancreatic cancer
    Osman, M. A. M.
    McDermott, R.
    Fennelly, D.
    ANNALS OF ONCOLOGY, 2016, 27
  • [9] Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
    Von Hoff, Daniel D.
    Ervin, Thomas
    Arena, Francis P.
    Chiorean, E. Gabriela
    Infante, Jeffrey
    Moore, Malcolm
    Seay, Thomas
    Tjulandin, Sergei A.
    Ma, Wen Wee
    Saleh, Mansoor N.
    Harris, Marion
    Reni, Michele
    Dowden, Scot
    Laheru, Daniel
    Bahary, Nathan
    Ramanathan, Ramesh K.
    Tabernero, Josep
    Hidalgo, Manuel
    Goldstein, David
    Van Cutsem, Eric
    Wei, Xinyu
    Iglesias, Jose
    Renschler, Markus F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (18): : 1691 - 1703
  • [10] Nab-paclitaxel and gemcitabine for the treatment of patients with metastatic pancreatic cancer
    Borazanci, Erkut
    Von Hoff, Daniel D.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2014, 8 (07) : 739 - 747
12345